Al-Ola Abdallah, Director of Plasma Cell Disorders Care at The University of Kansas Health System and Chair of USMIRC, shared on LinkedIn:
“43 speakers, panelists, and moderators. Multiple specialties. One shared mission: advancing cellular therapy.
Join us at the ICE-T Conference on November 7, 2027, in Kansas City, bringing together experts from across the United States – including oncologists, hematologists, neurologists, rheumatologists, stem cell transplant specialists, pharmacists, nurses, and nurse practitioners.
Through expert presentations, hands-on workshops, and interactive panel discussions, we will explore advances in cellular therapy, share practical insights, and strengthen collaboration across specialties and care settings.
From research to practice, and from referral to survivorship – every perspective matters.
Kansas City November 7, 2027.”
Other articles about Al-Ola Abdallah on OncoDaily.